ROBERT ECKERT - 10 Aug 2022 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Director
Signature
/s/ Andrea Robinson, Attorney-in-Fact for Mr. Eckert
Issuer symbol
AMGN
Transactions as of
10 Aug 2022
Net transactions value
-$143
Form type
4
Filing time
12 Aug 2022, 17:38:53 UTC
Previous filing
25 May 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Options Exercise $1,711,800 +20,000 +137% $85.59 34,575 10 Aug 2022 Direct
transaction AMGN Common Stock Tax liability $1,711,943 -6,791 -20% $252.09 27,784 10 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMGN Nqso (Right to Buy) Options Exercise $0 -20,000 -100% $0.000000* 0 10 Aug 2022 Common Stock 20,000 $85.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Non-market exercise of a total of 20,000 stock options expiring January 28, 2023 wherein 6,791 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price with the remaining shares delivered to the reporting person.
F2 These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.